Interestingly, disruption of GH signalling in growth hormone receptor (GHR)‐deficient mice leads to reduced β‐cell mass (due to decreased islet replication and growth), impaired glucose tolerance and lower pancreatic insulin content, compared with wild‐type mice.13 Here, GHR is linked to Impaired glucose tolerance.